Jpmorgan Chase & CO Covetrus, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $36.6 Million - $37 Million	1,769,262 Added 449.83%	2,162,578 $45.2 Million
Q2 2022 Aug 11, 2022	SELL	$13.8 - $20.82 $62.8 Million - $94.8 Million	-4,552,290 Reduced 92.05%	393,316 $8.16 Million
Q1 2022 May 11, 2022	BUY	$15.96 - $18.87 $2.41 Million - $2.86 Million	151,302 Added 3.16%	4,945,606 $83 Million
Q4 2021 Feb 10, 2022	BUY	$16.79 - $20.37 $4.46 Million - $5.41 Million	265,732 Added 5.87%	4,794,304 $95.7 Million
Q3 2021 Nov 12, 2021	BUY	$18.14 - $27.03 $82.1 Million - $122 Million	4,528,572 New	4,528,572 $82.1 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.